Is International Business Machines Stock Underperforming the S&P 500?

Valued at a market cap of $222 billion, International Business Machines Corporation (IBM) is a global enterprise technology and services company that helps businesses modernize their IT infrastructure and deploy AI across complex environments. Its portfolio spans software, hybrid cloud, AI, consulting and infrastructure, with Red Hat playing a central role in its hybrid-cloud strategy. The Armonk-headquartered company serves customers in more than 175 countries, with a particularly strong presence among large enterprises and highly regulated industries. 

Companies valued at $200 billion or more are typically classified as “mega-cap stocks,” and IBM fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the information technology services industry. IBM stands out for its deep enterprise relationships, differentiated hybrid-cloud and AI capabilities, and large recurring software base. 

This tech giant has fallen 29.7% from its 52-week high of $332.46, reached on June 2. Shares of IBM have dipped 21.5% over the past three months, trailing the S&P 500 Index ($SPX), which has rallied 1.4%. 

On a YTD basis, shares of IBM are down 21.1%, compared to SPX’s 12.3% rise. In the longer term, IBM has dropped 4.8% over the past 52 weeks, notably underperforming the index’s 18.2% uptick over the same time frame. 

IBM has fallen below its 50-day and 200-day moving averages since early July, indicating a downtrend.  

On Aug. 26, IBM completed its acquisition of HRL Laboratories, a leading R&D organization specializing in quantum computing, sensing, advanced communications, electronics, and materials science. The deal strengthens IBM’s quantum-computing capabilities by adding HRL’s expertise in silicon-spin qubits, quantum materials, cryogenics, control electronics, and advanced packaging, complementing IBM’s existing superconducting-qubit technology. The acquisition is expected to accelerate IBM’s quantum hardware roadmap and support scalable manufacturing, reinforcing its position in the race to develop fault-tolerant quantum computers. Investors were pleased with the development, and pushed IBM’s shares up 3.9% in the next trading session. 

IBM has outpaced its rival, Accenture plc (ACN), which dropped 25.9% over the past 52 weeks and 29.3% on a YTD basis. 

The stock has a consensus rating of "Moderate Buy” from the 21 analysts covering it, and the mean price target of $251.87 implies an upswing potential of 7.7% from the current market prices.